| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |